{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:55:03Z","timestamp":1769691303715,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81202479"],"award-info":[{"award-number":["81202479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Major Cultivation Item of Educational Department of Sichuan Province","award":["14CZ0018"],"award-info":[{"award-number":["14CZ0018"]}]},{"name":"Collaborative Fund of Science and Technology Agency of Sichuan Province, Luzhou Government and Southwest Medical University","award":["2014JC0126"],"award-info":[{"award-number":["2014JC0126"]}]},{"name":"Collaborative Fund of Science and Technology Agency of Sichuan Province, Luzhou Government and Southwest Medical University","award":["2014JC0800"],"award-info":[{"award-number":["2014JC0800"]}]},{"name":"Collaborative Fund of Luzhou Government and Southwest Medical University","award":["2013LZLY-J54"],"award-info":[{"award-number":["2013LZLY-J54"]}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.canlet.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T15:48:19Z","timestamp":1476114499000},"page":"230-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Enhanced growth inhibition of prostate cancer in\u00a0vitro and in\u00a0vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system"],"prefix":"10.1016","volume":"383","author":[{"given":"Pei","family":"Jing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shousong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangli","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-5843","authenticated-orcid":false,"given":"Siyun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shurong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-4540","authenticated-orcid":false,"given":"Zhirong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2016.10.003_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng0497-356","article-title":"Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers","volume":"15","author":"Steck","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2016.10.003_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature08361","article-title":"A\u00a0luminal epithelial stem cell that is a cell of origin for prostate cancer","volume":"461","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"38830","DOI":"10.1074\/jbc.M103632200","article-title":"PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression","volume":"276","author":"Huang","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cdp.2004.07.006","article-title":"PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer","volume":"29","author":"Tanaka","year":"2005","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.canlet.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11095-011-0521-7","article-title":"Co-delivery of adenovirus and carmustine by anionic liposomes with synergistic anti-tumor effects","volume":"29","author":"Zhong","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/jps.23556","article-title":"Evaluation of cell-penetrating peptide\/adenovirus particles for transduction of CAR-negative cells","volume":"102","author":"Nigatu","year":"2013","journal-title":"J.\u00a0Pham. Sci."},{"key":"10.1016\/j.canlet.2016.10.003_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.canlet.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In\u00a0vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"e31196","DOI":"10.1371\/journal.pone.0031196","article-title":"Probing high affinity sequences of DNA aptamer against VEGF165","volume":"7","author":"Kaur","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/nat.2011.0313","article-title":"Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling","volume":"21","author":"Rockey","year":"2011","journal-title":"Nucleic Acid. Ther."},{"key":"10.1016\/j.canlet.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/1078-0432.139.11.1","article-title":"A\u00a0new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy","volume":"11","author":"Zitzmann","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2011.02.015","article-title":"Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer","volume":"153","author":"Savla","year":"2011","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.canlet.2016.10.003_bib13","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1002\/anie.200602251","article-title":"An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform","volume":"45","author":"Bagalkot","year":"2006","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.canlet.2016.10.003_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0026-895X(25)10149-1","article-title":"Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells","volume":"45","author":"Fornari","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.canlet.2016.10.003_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.canlet.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.1016\/j.biomaterials.2013.03.006","article-title":"Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.canlet.2016.10.003_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nnm.15.183","article-title":"EGCG\/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment","volume":"11","author":"Tsai","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.canlet.2016.10.003_bib18","first-page":"1925","article-title":"Antitumor activity of ZD1694 against human head and neck cancer in nude mice models: role of dosing schedule and plasma thymidine","volume":"5","author":"Cao","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/11400","article-title":"Instability of adenoviral vectors during transport and its implication for clinical studies","volume":"5","author":"Nyberg-Hoffman","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/mp900151k","article-title":"Anionic liposomes increase the efficiency of adenovirus-mediated gene transfer to coxsackieadenovirus receptor deficient cells","volume":"7","author":"Zhong","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.canlet.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"Mittereder","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.canlet.2016.10.003_bib22","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm0797-808","article-title":"Sensitivity and reproducibility in adenoviral infectious titer determination","volume":"3","author":"Nyberg-Hoffman","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/marc.201000341","article-title":"Enhanced in\u00a0vivo magnetic resonance imaging of tumors by PEGlated iron-oxide-gold core-shell nanoparticles with prolonged blood circulation propertise","volume":"31","author":"Kumagai","year":"2010","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.canlet.2016.10.003_bib24","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/app.32494","article-title":"Gadolinium-conjugated FA-PEG-PAMAM-COOH nanoparticles as protential tumor-targeted circulation-prolonged macromolecular MRI contrast agents","volume":"118","author":"Zhang","year":"2010","journal-title":"J.\u00a0Appl. Polym. Sci."},{"key":"10.1016\/j.canlet.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/(SICI)1097-4636(1999)48:2<143::AID-JBM8>3.0.CO;2-8","article-title":"Effect of mixing method and storage temperature of cement constituents on the fatigue and porosity of acrylic bone cement","volume":"48","author":"Lewis","year":"1999","journal-title":"J.\u00a0Biomed. Mater. Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib26","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/hum.2004.15.1167","article-title":"Adenovirus structure","volume":"15","author":"Rux","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2016.10.003_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00216-015-9168-2","article-title":"DNA sequence-dependent fluorescence of doxorubicin for turn-on detection of biothiols in human serum","volume":"408","author":"Chen","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.canlet.2016.10.003_bib28","first-page":"282","article-title":"Killing effect to hepatoma cell SMMC-7721 by dual-regulated oncolytic adenovirus-mediated TSLC1 combined with adriamycin","volume":"3","author":"Guo","year":"2013","journal-title":"Chin. J. Cell Biol."},{"key":"10.1016\/j.canlet.2016.10.003_bib29","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1007\/s11095-014-1320-8","article-title":"Targeted paclitaxel delivery to tumors using cleavable PEG-conjugated solid lipid nanoparticles","volume":"31","author":"Zheng","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib30","first-page":"1921","article-title":"Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers","volume":"7","author":"Guan","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.canlet.2016.10.003_bib31","first-page":"169","article-title":"Antioxidant and protective effect of an oleanolic acidenriched extract of A.\u00a0deliciosa root on carbon tetrachloride induced rat liver injury","volume":"16","author":"Bai","year":"2007","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.canlet.2016.10.003_bib32","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s12272-012-1013-y","article-title":"In\u00a0vivo prophylactic effects of oleanolic acid isolated from chloroform extract of Flaveria trinervia against ethanol induced liver toxicity in rats","volume":"35","author":"Joy Hoskeri","year":"2012","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.canlet.2016.10.003_bib33","first-page":"5039","article-title":"Mannan-modifid Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice","volume":"7","author":"Liu","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.canlet.2016.10.003_bib34","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.nano.2013.02.010","article-title":"PEGylated FePt@Fe2O3 core-shell magnetic nanoparticles: potential theranostic applications and in\u00a0vivo toxicity studies","volume":"9","author":"Liu","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.canlet.2016.10.003_bib35","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/bjc.2014.85","article-title":"Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumor activity of anticancer drugs in preclinical animal models","volume":"110","author":"Cao","year":"2014","journal-title":"Brit. J. Cancer"},{"key":"10.1016\/j.canlet.2016.10.003_bib36","first-page":"1747","article-title":"Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy","volume":"6","author":"Wu","year":"2011","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.canlet.2016.10.003_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1089\/10430349950018021","article-title":"PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in\u00a0vitro and in\u00a0vivo","volume":"10","author":"O'Riordan","year":"1999","journal-title":"Hum. Gene Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516306103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383516306103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:47:09Z","timestamp":1749617229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383516306103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0304383516306103"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2016.10.003","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced growth inhibition of prostate cancer in\u00a0vitro and in\u00a0vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}